US equities |
NVDA $241.26 ▲+0.99% SPCX $173.54 ▲+1.43% MU $1,064.11 ▲+0.01% AMD $656.50 ▲+3.92% MRVL $281.75 ▲+3.87% SNDK $1,670.39 ▼-1.98% AVGO $378.16 ▲+4.32% INTC $113.35 ▼-2.44%
FinancialContent

Certara, Inc. - Common Stock (NQ:CERT)

9.410 -0.660 (-6.55%)
Delayed Quote Updated: 12:17 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
The Market Just Told You Which Layer Of AI Biology It Is Paying For
Issued on behalf of MindWalk Holdings Corp. 
From Market Updates
Via GlobeNewswire
News headline image
Certara (CERT) Q2 2026 Earnings Call Transcript ↗
Software revenue hit 53% of total as AI-assisted code boosted development 65% year over year. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Certara Q2 Earnings Call Highlights ↗
Certara (NASDAQ:CERT) reported second-quarter 2026 revenue of $93.3 million, up 1% year over year, as software growth offset a decline in services revenue. Management reaffirmed its full-year revenue... 
Via MarketBeat
Topics Artificial Intelligence Earnings
Certara (NASDAQ:CERT) Q1 2026: Software Shines, but Divestiture and Mixed Metrics Weigh on Shares ↗
Via Chartmill
News headline image
Transcript: Certara Q2 2026 Earnings Conference Call ↗
Certara (NASDAQ:CERT) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga... 
Via Benzinga
Topics Earnings
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
Certara Reports Second Quarter 2026 Financial Results
From Certara
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
From Pomerantz LLP
Via GlobeNewswire
News headline image
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
From Certara
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
From Pomerantz LLP
Via GlobeNewswire
News headline image
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
New capabilities unify Certara's biosimulation software, products, datasets, and scientific expertise with AI-driven agents to deliver specialized insights for life sciences 
From Certara
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
From Pomerantz LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Certara Announces CFO Transition
Reaffirms 2026 Guidance 
From Certara
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
From Pomerantz LLP
Via GlobeNewswire
News headline image
Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference ↗
Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT
From Pomerantz LLP
Via GlobeNewswire
News headline image
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via Business Wire
News headline image
CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
News headline image
CERTARA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
CERTARA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
From Kirby McInerney LLP
Via Business Wire
News headline image
Certara (CERT) Q1 2026 Earnings Call Transcript ↗
Certara (CERT) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Certara Q1 Earnings Call Highlights ↗
Certara (NASDAQ:CERT) reported first-quarter 2026 revenue of $106.9 million, up 1% from the prior-year period, as stronger software performance offset softer services results and the company outlined a... 
Via MarketBeat
Topics Earnings
News headline image
Certara Reports First Quarter 2026 Financial Results
Updates 2026 Guidance to reflect completed divestiture of Regulatory Writing and Medical Writing Business 
From Certara
Via GlobeNewswire
News headline image
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development
From Altasciences
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >